Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

PF-1355

🥰Excellent
Catalog No. T3511Cas No. 1435467-38-1
Alias ZINC205721785, PF-06281355, PF 06281355

PF-1355 (PF 06281355) is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.

PF-1355

PF-1355

🥰Excellent
Purity: 99.77%
Catalog No. T3511Alias ZINC205721785, PF-06281355, PF 06281355Cas No. 1435467-38-1
PF-1355 (PF 06281355) is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.
Pack SizePriceAvailabilityQuantity
2 mg$30In Stock
5 mg$43In Stock
10 mg$73In Stock
25 mg$118In Stock
50 mg$223In Stock
100 mg$322In Stock
200 mg$460In Stock
500 mgInquiryIn Stock
1 mL x 10 mM (in DMSO)$47In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "PF-1355"

Select Batch
Purity:99.77%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
PF-1355 (PF 06281355) is a selective 2-thiouracil mechanism-based MPO inhibitor. PF-1355 is used for treatment of vasculitic diseases.
In vitro
PF-1355 inhibits MPO activity in phorbol ester-stimulated human neutrophils as measured by taurine chlorination (EC50=1.47 μM) as well as lipopolysaccharide-treated human blood measuring residual MPO activity (EC50=2.03 μM) [1].
In vivo
Administering PF-1355 orally diminishes MPO activity in plasma, lessens vascular edema and neutrophil recruitment, and increases circulating cytokines levels. PF-1355 treatment entirely inhibits albuminuria and chronic renal dysfunction in a model of anti-glomerular basement membrane disease [1].
AliasZINC205721785, PF-06281355, PF 06281355
Chemical Properties
Molecular Weight321.35
FormulaC14H15N3O4S
Cas No.1435467-38-1
SmilesCOc1ccc(OC)c(c1)-c1cc(=O)[nH]c(=S)n1CC(N)=O
Relative Density.1.43 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (171.15 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.1119 mL15.5594 mL31.1187 mL155.5936 mL
5 mM0.6224 mL3.1119 mL6.2237 mL31.1187 mL
10 mM0.3112 mL1.5559 mL3.1119 mL15.5594 mL
20 mM0.1556 mL0.7780 mL1.5559 mL7.7797 mL
50 mM0.0622 mL0.3112 mL0.6224 mL3.1119 mL
100 mM0.0311 mL0.1556 mL0.3112 mL1.5559 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy PF-1355 | purchase PF-1355 | PF-1355 cost | order PF-1355 | PF-1355 chemical structure | PF-1355 in vivo | PF-1355 in vitro | PF-1355 formula | PF-1355 molecular weight